Results 91 to 100 of about 2,238,578 (328)
Factors predicting long-term comorbidities in patients with Cushing’s syndrome in remission
Endocrine, 2018 PurposeIn Cushing’s syndrome, comorbidities often persist after remission of glucocorticoid excess. Here, we aim to identify factors predicting long-term comorbidities in patients with Cushing’s syndrome in remission.MethodsIn a retrospective cross ...
M. Schernthaner-Reiter +8 more
semanticscholar +1 more source
iMeta, EarlyView.By integrating multi‐level and multi‐omics analyses, we identify 3,4‐dihydroxyphenylacetic acid (DHPAA), a gut microbiota‐derived degradation product of dietary flavonoids, as a key bioactive end‐product responsible for the beneficial effects against polycystic ovary syndrome (PCOS).
Pan Li +22 more
wiley +1 more source
Rectal budesonide: A potential game changer after Kasai hepatoportoenterostomy
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.Abstract Objectives Intravenous or oral steroid administration in patients with biliary atresia (BA) after Kasai hepatoportoenterostomy (HPE) is commonly practiced, however, the benefits remain controversial. Some studies suggest no positive effects while risking steroid associated side effects.
Stefanie Langreen +8 more
wiley +1 more source
Nested stromal epithelial tumor of liver presenting with Cushing syndrome: A Rare case Report
Indian Journal of Pathology and Microbiology, 2012 Nested stromal and epithelial tumor of the liver is an extremely rare pediatric hepatic tumor. To the best of our knowledge, about 25 cases have been reported in the English literature so far, few of which accompanied with Cushing syndrome.
Bita Geramizadeh +3 more
doaj +1 more source
Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat [PDF]
, 2019 In this paper we report a case of iatrogenic Cushing syndrome due to a pharmacological interaction between fluticasone and cobicistat. Inhaled corticosteroids were previously thought to be safe, but increasing numbers of cases of iatrogenic Cushing ...
A. Giacomelli, E. Monge, V. Colombo
core
Cushing syndrome, metabolic syndrome and inflammation: a suggested way out [PDF]
, 2013 Endogenous hypercortisolism is associated with an increased cardiovascular risk. Cushing Syndrome (CS) shares many clinical features with metabolic syndrome, including abdominal obesity, systemic arterial hypertension, insulin resistance, dyslipidemia ...
Bellastella, Giuseppe +5 more
core +1 more source
Molecular Nutrition &Food Research, EarlyView.Over half of patients with colorectal cancer experience severe chemotherapy‐induced side effects. The B‐vitamin folate may play a role in these side effects, potentially by altering DNA methylation, a mechanism of gene regulation. Our comprehensive literature search identified studies investigating DNA methylation associated with folate status/intake ...
Nienke R. K. Zwart +3 more
wiley +1 more source
Subclinical Cushing’s syndrome
Best Practice & Research Clinical Endocrinology & Metabolism, 2012 The routine use of abdominal procedure has significantly increased the incidental finding of adrenal masses. The prevalence of these tumors, commonly defined as adrenal incidentalomas, ranges between 2-3% in autopsy and 4% in radiological series, reaching 5-8% in oncological studies and increasing with patients age. Although clinically silent, in 5-20%
De Leo M +3 more
openaire +10 more sources
Cushing Syndrome and Subclinical Cushing Syndrome
Nihon Naika Gakkai Zasshi, 2023 Hirotaka Shibata
semanticscholar +1 more source
Frontiers in Endocrinology, 2018 Objective Central serous chorioretinopathy (CSC), a specific form of macular degeneration, has been reported as presenting manifestation of Cushing’s syndrome.
F. V. van Haalen +7 more
semanticscholar +1 more source